Literature DB >> 15913635

The inverse relationship between serum high-density lipoprotein cholesterol level and all-cause mortality in a 9.6-year follow-up study in the Japanese general population.

Tomonori Okamura1, Takehito Hayakawa, Takashi Kadowaki, Yoshikuni Kita, Akira Okayama, Hirotsugu Ueshima.   

Abstract

In populations with higher high-density lipoprotein cholesterol (HDL-C) levels and lower coronary mortality than Western populations, such as in Japan, the beneficial effect of HDL-C on all-cause mortality may be different. Furthermore, prior studies have not focused on very high level of HDL-C. A total of 7175 community Japanese residents without a past history of cardiovascular disease in 300 randomly selected districts were followed for 9.6 years. During follow-up, there were 636 deaths. The multivariate adjusted hazard ratio (HR) of HDL-C for all-cause or cause-specific mortality was calculated using a Cox proportional hazard model adjusted for other cardiovascular risk factors. The all-cause mortality suggested an inverse, graded relation with HDL-C categories; HR for the very high HDL-C category (> or = 1.82 mmol/L), compared with the reference group (1.04-1.55 mmol/L), was 0.73 (95% confidence interval, C.I., 0.50-1.06) for men, 0.63 (95% C.I., 0.41-0.94) for women and 0.70 (95% C.I., 0.53-0.93) when men and women were combined. Serum HDL-C as a continuous variable showed a significant inverse association with all-cause mortality. The cardiovascular mortality indicated a non-significant but inverse graded relation with HDL-C categories. As in the many Western populations, serum HDL-C levels were inversely associated with all-cause mortality in the Japanese general population.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 15913635     DOI: 10.1016/j.atherosclerosis.2005.03.042

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  34 in total

1.  The Relationship between Very High Levels of Serum High-Density Lipoprotein Cholesterol and Cause-Specific Mortality in a 20-Year Follow-Up Study of Japanese General Population.

Authors:  Aya Hirata; Tomonori Okamura; Daisuke Sugiyama; Kazuyo Kuwabara; Aya Kadota; Akira Fujiyoshi; Katsuyuki Miura; Nagako Okuda; Takayoshi Ohkubo; Akira Okayama; Hirotsugu Ueshima
Journal:  J Atheroscler Thromb       Date:  2016-02-26       Impact factor: 4.928

2.  Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017.

Authors:  Makoto Kinoshita; Koutaro Yokote; Hidenori Arai; Mami Iida; Yasushi Ishigaki; Shun Ishibashi; Seiji Umemoto; Genshi Egusa; Hirotoshi Ohmura; Tomonori Okamura; Shinji Kihara; Shinji Koba; Isao Saito; Tetsuo Shoji; Hiroyuki Daida; Kazuhisa Tsukamoto; Juno Deguchi; Seitaro Dohi; Kazushige Dobashi; Hirotoshi Hamaguchi; Masumi Hara; Takafumi Hiro; Sadatoshi Biro; Yoshio Fujioka; Chizuko Maruyama; Yoshihiro Miyamoto; Yoshitaka Murakami; Masayuki Yokode; Hiroshi Yoshida; Hiromi Rakugi; Akihiko Wakatsuki; Shizuya Yamashita
Journal:  J Atheroscler Thromb       Date:  2018-08-22       Impact factor: 4.928

3.  HDL cholesterol performance using an ultracentrifugation reference measurement procedure and the designated comparison method.

Authors:  Masakazu Nakamura; Shinji Yokoyama; Yuzo Kayamori; Hiroyasu Iso; Akihiko Kitamura; Tomonori Okamura; Masahiko Kiyama; Hiroyuki Noda; Kunihiro Nishimura; Michikazu Nakai; Isao Koyama; Mahnaz Dasti; Hubert W Vesper; Tamio Teramoto; Yoshihiro Miyamoto
Journal:  Clin Chim Acta       Date:  2014-10-31       Impact factor: 3.786

4.  Relationship of three different types of low-carbohydrate diet to cardiometabolic risk factors in a Japanese population: the INTERMAP/INTERLIPID Study.

Authors:  Yasuyuki Nakamura; Hirotsugu Ueshima; Nagako Okuda; Katsuyuki Miura; Yoshikuni Kita; Naoko Miyagawa; Katsushi Yoshita; Hideaki Nakagawa; Kiyomi Sakata; Shigeyuki Saitoh; Tomonori Okamura; Akira Okayama; Sohel R Choudhry; Beatriz Rodriguez; Kamal H Masaki; Queenie Chan; Paul Elliott; Jeremiah Stamler
Journal:  Eur J Nutr       Date:  2015-06-29       Impact factor: 5.614

5.  A dose-response meta-analysis to evaluate the relationship between high-density lipoprotein cholesterol and all-cause and cardiovascular disease mortality.

Authors:  L Liu; M Han; R Qie; Q Li; X Zhang; J Zhang; S Zhan; L Zhang; Z Xu; C Zhang; F Hong
Journal:  J Endocrinol Invest       Date:  2021-10-21       Impact factor: 4.256

6.  Population attributable fraction of smoking and metabolic syndrome on cardiovascular disease mortality in Japan: a 15-year follow up of NIPPON DATA90.

Authors:  Naoyuki Takashima; Katsuyuki Miura; Atsushi Hozawa; Aya Kadota; Tomonori Okamura; Yasuyuki Nakamura; Takehito Hayakawa; Nagako Okuda; Akira Fujiyoshi; Shin-Ya Nagasawa; Takashi Kadowaki; Yoshitaka Murakami; Yoshikuni Kita; Akira Okayama; Hirotsugu Ueshima
Journal:  BMC Public Health       Date:  2010-06-03       Impact factor: 3.295

7.  Low high-density lipoprotein cholesterol is a residual risk factor associated with long-term clinical outcomes in diabetic patients with stable coronary artery disease who achieve optimal control of low-density lipoprotein cholesterol.

Authors:  Manabu Ogita; Katsumi Miyauchi; Tadashi Miyazaki; Ryo Naito; Hirokazu Konishi; Shuta Tsuboi; Tomotaka Dohi; Takatoshi Kasai; Takayuki Yokoyama; Shinya Okazaki; Takeshi Kurata; Hiroyuki Daida
Journal:  Heart Vessels       Date:  2013-03-21       Impact factor: 2.037

8.  Serum lipid management in patients with type 1 and type 2 diabetes: a hospital-based cohort study.

Authors:  Yukiko Hasegawa; Tomoko Nakagami; Junko Oya; Chisato Isago; Moritoshi Kurita; Yuki Tanaka; Arata Ito; Reika Tsuzura; Naoki Hirota; Junnosuke Miura; Yasuko Uchigata
Journal:  Diabetol Int       Date:  2018-07-28

9.  Switching to Pitavastatin in Statin-Treated Low HDL-C Patients Further Improves the Lipid Profile and Attenuates Minute Myocardial Damage.

Authors:  Chikao Ibuki; Yoshihiko Seino; Toshiaki Otsuka; Nakahisa Kimata; Toru Inami; Ryo Munakata; Kyoichi Mizuno
Journal:  J Clin Med Res       Date:  2012-11-11

10.  The proportion of individuals with obesity-induced hypertension among total hypertensives in a general Japanese population: NIPPON DATA80, 90.

Authors:  Koshi Nakamura; Tomonori Okamura; Takehito Hayakawa; Atsushi Hozawa; Takashi Kadowaki; Yoshitaka Murakami; Yoshikuni Kita; Akira Okayama; Hirotsugu Ueshima
Journal:  Eur J Epidemiol       Date:  2007-08-07       Impact factor: 12.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.